Use of prior authorization and step therapy prohibition for drugs used in the treatment of opioid use disorder under medical assistance
Introduction and first reading; Referred to
Email me when SF 3822 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SF 3822. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill amends Minnesota’s Medicaid drug‑coverage rules to bar the use of prior authorization or step‑therapy protocols for any medication that the FDA has approved to treat opioid use disorder. It applies to all drugs in that class covered under the state’s medical assistance program, ensuring patients can obtain treatment without extra administrative hurdles. The change is intended to improve access to life‑saving medication for people with opioid addiction.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SF 3822
3 free questions a day, no accountHearings
- Health and Human ServicesHealth and Human Services · Apr 9, 2026
History
- Referred to Health and Human Services
- Introduction and first reading
Sponsors
- Fateh · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SF 3822 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SF 3822 freeOr ask your AI assistant about SF 3822 directly:
Add to Claude, ChatGPT or Cursor